Schedule 13G ownership disclosure

Phio Pharmaceuticals Corp.

Security class unavailable · CUSIP: 71880W303

Event date: 2020-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
428,266
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-044916
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Apr 09, 2020
Reporting period
Mar 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub